Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

07. Avril 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2982


	Articles 1 - 20 / 59623

	Pancreatic cancer-associated myofibroblasts: a review. Int J Biol Sci Banacki M, Inkielewicz-Stepniak I. PMID: 41943847 [PubMed - indexed for MEDLINE]
	Integrative multimodal transcriptomics identifies a cancer-associated fibroblast membrane signature for predicting prognosis and therapeutic response in pancreatic ductal adenocarcinoma. J Mol Med (Berl) Zhuang L, Zhang W, Wu J, Cao J, Feng L, Cao S. PMID: 41942785 [PubMed - indexed for MEDLINE]
	Emerging Therapeutic Landscapes for KRAS-Mutant Pancreatic Ductal Adenocarcinoma: Beyond the "Undruggable" Paradigm. Turk J Gastroenterol Li W, Lin X, Liu P, Zhang J, Liu C. PMID: 41942368 [PubMed - indexed for MEDLINE]
	Impact of immunosuppressive therapy on non-melanoma skin cancer after solid organ transplantation: A critical systematic review. Transpl Immunol Abulail JA, Husein SA, Al-Tamimia M, Jaradat M, Alhawamdeh S, Elkhalili Z, Esaid R, Saleh T, Al Shboul S. PMID: 41941970 [PubMed - as supplied by publisher]
	pRECIST: Guidelines for Response Criteria for Use in Trials Testing Therapeutics in Pancreatic Cancer. Pancreas Martin RCG 2nd, Scheon E, Govindarajan N, Verdeur M, Justin J, Shamsi K. PMID: 41941588 [PubMed - as supplied by publisher]
	Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring. Front Immunol Zhao WY, Zhao JW. PMID: 41939911 [PubMed - indexed for MEDLINE]
	Correction: Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis. Front Med (Lausanne) Cretu OI, Lungulescu CV, Gentiluomo M, Turcu-Stiolica A, Pani, Patrascu S, Ungureanu BS. PMID: 41939785 [PubMed]
	Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions. Front Oncol Diao Z, Wang Y, Mu S, Wu X, Yu S, Wang Z. PMID: 41939454 [PubMed]
	Beyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms. Front Endocrinol (Lausanne) La Salvia A, Fanciulli G. PMID: 41938105 [PubMed - indexed for MEDLINE]
	Impact of Male Sex and Umbilical-Pancreatic Anatomy on Surgical Difficulty in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis. Asian J Endosc Surg Fukada M, Mitsui N, Horaguchi T, Yasufuku I, Sato Y, Tajima JY, Tanaka Y, Matsuhashi N. PMID: 41936535 [PubMed - indexed for MEDLINE]
	Unmasking FCGR2B as a high-grade serous ovarian cancer specific marker of immune suppression and tumor progression through multi-omics mining. Transl Oncol Zhou J, Zeng T, Ye M, Li M, Wen L, Liu X, Zhang Z, Meng Y. PMID: 41934917 [PubMed - as supplied by publisher]
	Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. Trends Endocrinol Metab Costamagna A, Milan G, De Santis MC, Carrer A, Martini M. PMID: 41933959 [PubMed - as supplied by publisher]
	Tumor Evolution in an Ecological Context: How Genetic and Microenvironmental Factors Shape the Pathogenesis of Pancreatic Cancer. Crit Rev Oncol Hematol Girolimetti G, Bramato G, Fiore A, Romano R, Guerra F, Bucci C, Basset A. PMID: 41933855 [PubMed - as supplied by publisher]
	Demographic and Prognostic Significance of Surgically-Treated Intrathyroidal Thymic Carcinoma: A Systematic Review and Meta-Analysis. World J Surg Jenkins CR, Hajibandeh S, Hajibandeh S, Scott-Coombes DM, Egan RJ. PMID: 41931541 [PubMed - as supplied by publisher]
	Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysis. Eur J Cancer Filis P, Markozannes G, Salgkamis D, Tsiknakis N, Zerdes I, Pagkalidou E, Manou M, Filis N, Papakonstantinou A, Mavroudis D, Matikas A, Tsilidis KK, Foukakis T. PMID: 41930854 [PubMed - as supplied by publisher]
	Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives. Oncol Res Wang S, Wang M, Yao W. PMID: 41930147 [PubMed - indexed for MEDLINE]
	Presentation, Treatment, and Outcomes of Non-bacterial Thrombotic Endocarditis in Pancreatic Cancer: A Systematic Review. Cureus Hussain F, Huba M, Paracha A, Kwait B, Siddiqui Z, Patel H, Lee A, Patel H, Palati S, Papale A, Copeland-Halperin RS, King D. PMID: 41930062 [PubMed]
	Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic. Front Immunol Yan J, Ou H, Wang S, Jin K, Yu X, Wu W. PMID: 41929491 [PubMed - indexed for MEDLINE]
	Automated Extraction of Cancer Registry Data from Pathology Reports: Comparing LLM-Based and Ontology-Driven NLP Platforms. medRxiv McPhaul T, Kreimeyer K, Baras A, Botsis T. PMID: 41929331 [PubMed]
	Osteopontin in pancreatic cancer: A systematic review. Med Int (Lond) Weber GF. PMID: 41928921 [PubMed]

Articles 1 - 20 / 59623

Page 1 de 2982



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité